Keshvari, T.; Melnik, S.; Sun, L.; Niazi, A.; Aram, F.; Moghadam, A.; Kogelmann, B.; Wozniak-Knopp, G.; Kallolimath, S.; Ramezani, A.;
et al. Efficient Expression of Functionally Active Aflibercept with Designed N-glycans. Antibodies 2024, 13, 29.
https://doi.org/10.3390/antib13020029
AMA Style
Keshvari T, Melnik S, Sun L, Niazi A, Aram F, Moghadam A, Kogelmann B, Wozniak-Knopp G, Kallolimath S, Ramezani A,
et al. Efficient Expression of Functionally Active Aflibercept with Designed N-glycans. Antibodies. 2024; 13(2):29.
https://doi.org/10.3390/antib13020029
Chicago/Turabian Style
Keshvari, Tahereh, Stanislav Melnik, Lin Sun, Ali Niazi, Farzaneh Aram, Ali Moghadam, Benjamin Kogelmann, Gordana Wozniak-Knopp, Somanath Kallolimath, Amin Ramezani,
and et al. 2024. "Efficient Expression of Functionally Active Aflibercept with Designed N-glycans" Antibodies 13, no. 2: 29.
https://doi.org/10.3390/antib13020029
APA Style
Keshvari, T., Melnik, S., Sun, L., Niazi, A., Aram, F., Moghadam, A., Kogelmann, B., Wozniak-Knopp, G., Kallolimath, S., Ramezani, A., & Steinkellner, H.
(2024). Efficient Expression of Functionally Active Aflibercept with Designed N-glycans. Antibodies, 13(2), 29.
https://doi.org/10.3390/antib13020029